Knowing stock market today at a glance

Why Did Affimed Plunge 35.13%? Nasdaq Delisting, Insolvency Filing

Mover TrackerMonday, May 19, 2025 4:18 am ET

1min read

On May 19, 2025, Affimed's stock experienced a significant drop of 35.13% in pre-market trading.

Affimed, a biopharmaceutical company, has recently faced a series of challenges that have impacted its stock performance. The company announced that it has received a delisting notice from Nasdaq, effective from May 20, 2025. This decision follows Affimed's insolvency filing in the Mannheim court, Germany, on May 13, 2025. The delisting is based on concerns related to public interest, existing shareholders' residual equity, and the company's ability to maintain Nasdaq listing requirements. Affimed has stated that it does not plan to appeal this determination.

Additionally, Affimed has been navigating through financial difficulties, which have led to a significant decline in its stock value. The company's recent insolvency filing and the subsequent delisting notice from Nasdaq have raised concerns among investors about the company's future prospects. These developments have contributed to the sharp drop in Affimed's stock price, reflecting the market's pessimistic outlook on the company's financial health and operational viability.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.